GlassScriptPhysician profile
Sara June White
NPI 1477211225
$4,031.02
in general payments reported to CMS, 2019-2025
42 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.85 · 2022: $2,435 · 2023: $1,189 · 2024: $167 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,557.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $448.85 | 2022-2025 | Jakafi, Monjuvi |
| E.R. Squibb & Sons, L.L.C. | $338.37 | 2022-2023 | Opdualag |
| Genzyme Corporation | $223.22 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $218.40 | 2022-2023 | |
| Intrinsiq Specialty Solutions, INC. | $214.38 | 2022 | |
| Merck Sharp & Dohme LLC | $200.25 | 2022-2023 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals LP | $192.11 | 2022-2023 | Lynparza |
| Pfizer INC. | $191.29 | 2023 | |
| Daiichi Sankyo INC. | $179.46 | 2022-2025 | Enhertu |
| Astellas Pharma US INC | $171.44 | 2022-2024 | Xospata |
| Janssen Biotech, INC. | $151.39 | 2022-2025 | Rybrevant |
| Pharmaessentia USA Corporation | $135.24 | 2022-2023 | Besremi |
| Ipsen Biopharmaceuticals, INC | $122.62 | 2021-2025 | Onivyde, Somatuline Depot |
| Glaxosmithkline, LLC. | $102.59 | 2022-2023 | |
| Amgen INC. | $100.35 | 2022-2023 | Lumakras |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.